🇺🇸 US Stock Screener ← Switch market ★ Elite Club ⚡ HerAI

MOH MOH

Company Profile ↓
$195.14
+23.39% 1Y
P/E21.88
52W High$242.88
52W Low$122.65
EPS (TTM)$8.92

Company Overview

MOH (MOH) is a publicly traded company listed on . The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.

Why Investors Should Care

Consistent Profit Growth

Net profit has compounded at 15.4% per year over the last five years.

Steady Revenue Expansion

Revenue has grown at a 17.4% CAGR over the past five years.

Recent Developments

  • Dec 2025 Revenue of $45.43B (+11.7% YoY); net profit $472.00M.
  • Trailing 12 Months Year-on-year growth — revenue +11.8%, earnings -60.0%.
  • 5-Year Trend Long-term compounding — revenue CAGR 17.4%, profit CAGR 15.4%.

Growth & Price Performance

Compounded Sales Growth

5 Years:17.42%
1 Year:11.75%

Compounded Profit Growth

5 Years:15.41%
1 Year:-59.97%

Stock Price Performance

1 Year:+23.39%
6 Months:+7.57%
3 Months:+1.55%
1 Month:-16.21%

Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.

Technical Snapshot Mixed
52-Week Range 60% of range
$122.65 $242.88
Trend Signals
  • Price vs 50-DMABelow
  • Price vs 200-DMAAbove
  • RSI (14)37.55 · Neutral
Price Performance
1M-16.21%
3M+1.55%
6M+7.57%
1Y+23.39%

Auto-generated from price history and fundamentals; not investment advice.

⚙Ad space

Price Chart

Robinhood TradingView

Fundamental Growth Charts

Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.

PROS

  • Compounding revenue at 17.4% over 5 years.
  • Profit CAGR of 15.4% over 5 years.
  • In a confirmed uptrend (50-DMA above 200-DMA).

CONS

No notable concerns flagged.

* The pros and cons are auto-generated from financial metrics.

⚙Ad space

Valuation

Stock P/E
21.88
Industry PE
-
Forward P/E est.
43.76
PEG Ratio
-
Book Value
$-
Price to Book
-
P/S
-
EV/EBITDA
-
Dividend Yield
0.00%

Growth (CAGR)

Revenue 5Y
17.42%
Profit 5Y
15.41%
Revenue (YoY)
11.75%
Earnings (YoY)
-59.97%

Profitability & Returns

ROCE
9.53%
ROE
11.60%
ROA
3.03%
Profit Margin
1.04%
Op Margin
1.72%
Gross Margin
5.46%
EPS (Latest Qtr)
$1.19
EPS (TTM)
$8.92

Balance Sheet & Liquidity

Debt/Equity
0.95
Quick Ratio
-
Current Ratio
1.68
Debt
$3.95B
Total Assets
$16.00B
Current Assets
$12.93B
Working Capital
$5.23B

Ownership

Promoter Holding
1.42%
Chg in Prom Hold
-
FII / Inst Holding
117.07%
Chg in FII Hold
-

Financial Snapshot

Enterprise Value
-
Total Revenue (TTM)
$45.43B
EBITDA
-
Free Cash Flow
$-636.00M
Operating Cash Flow
$-535.00M
Shares Outstanding
-
Gross Margin
5.46%
Payout Ratio
-
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios

Quarterly Results

Figures in USD.

Metric Mar 2015Jun 2015Sep 2015Dec 2015Mar 2016Jun 2016Sep 2016Dec 2016Mar 2017Jun 2017Sep 2017Dec 2017Mar 2018Jun 2018Sep 2018Dec 2018Mar 2019Jun 2019Sep 2019Dec 2019Mar 2020Jun 2020Sep 2020Mar 2021Jun 2021Sep 2021Mar 2022Jun 2022Sep 2022Mar 2023Jun 2023Sep 2023Mar 2024Jun 2024Sep 2024Mar 2025Jun 2025Sep 2025Mar 2026Jun 2026
Revenue 3.17B3.52B3.61B-4.34B4.36B4.55B4.53B4.90B5.00B5.03B4.95B4.65B4.88B4.70B4.66B4.12B4.19B4.24B4.27B4.55B4.62B5.02B6.52B6.80B7.04B7.77B8.05B7.93B8.15B8.33B8.55B9.93B9.88B10.34B11.15B11.43B11.48B10.80B10.87B
Gross Profit 351.00M389.00M374.00M-434.00M466.00M471.00M354.00M546.00M254.00M564.00M446.00M615.00M673.00M566.00M664.00M581.00M583.00M561.00M578.00M--------------------
Operating Income 82.00M116.00M113.00M76.00M89.00M105.00M118.00M-6.00M82.00M-287.00M-81.00M-222.00M342.00M295.00M-280.00M265.00M257.00M-274.00M424.00M289.00M335.00M273.00M221.00M372.00M361.00M335.00M455.00M443.00M359.00M426.00M434.00M467.00M433.00M373.00M137.00M83.00M145.00M
Net Income 28.00M39.00M46.00M30.00M24.00M33.00M42.00M-47.00M77.00M-230.00M-97.00M-262.00M107.00M202.00M197.00M201.00M198.00M196.00M175.00M168.00M178.00M276.00M185.00M228.00M185.00M143.00M258.00M248.00M230.00M321.00M309.00M245.00M301.00M301.00M326.00M298.00M255.00M79.00M14.00M60.00M
Diluted EPS 0.560.720.770.520.430.580.76-0.851.37-4.10-1.70-4.591.643.022.903.012.993.062.752.672.924.653.103.893.162.464.394.253.955.525.354.215.175.175.655.454.751.510.271.19

Profit & Loss (Annual)

Figures in USD.

Metric Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue 4.09B4.54B5.91B6.59B9.67B14.18B17.78B19.88B18.89B16.83B19.42B27.77B31.97B34.07B40.65B45.43B
Gross Profit ---843.00M1.00B1.53B1.73B1.81B2.52B2.30B2.48B-----
Operating Income 105.00M135.82M41.09M137.00M193.00M387.00M306.00M-555.00M1.13B1.04B1.08B1.02B1.17B1.57B1.71B781.00M
Net Income 54.97M20.82M9.79M53.00M62.00M143.00M52.00M-512.00M707.00M737.00M673.00M659.00M792.00M1.09B1.18B472.00M
Diluted EPS 1.320.450.211.131.292.580.92-9.0710.6111.4711.2311.2513.5518.7720.428.92

Balance Sheet (Annual)

Figures in USD.

Metric Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Total Assets --1.65B1.93B2.99B4.43B6.58B7.45B8.47B7.15B6.79B9.53B12.21B12.31B14.89B15.63B15.56B
Total Equity 542.74M719.06M755.07M782.31M892.94M1.01B1.56B1.65B1.34B1.65B1.96B2.10B2.63B2.96B4.21B4.50B4.07B
Cash & Equivalents 469.50M455.89M493.83M796.00M936.00M1.54B2.33B2.82B3.19B2.83B2.45B4.15B4.44B4.01B4.85B4.66B4.25B
Long Term Debt --216.93M261.78M737.00M690.00M1.16B975.00M1.32B1.02B1.24B2.13B2.17B2.18B2.18B2.92B3.77B
Total Liabilities --897.07M1.15B2.11B3.42B5.02B5.80B7.13B5.51B4.83B7.44B9.58B9.35B10.68B11.13B11.49B
Current Liabilities --601.83M828.04M1.29B2.17B3.82B4.57B5.56B4.25B3.27B4.96B7.05B6.86B8.17B7.90B7.37B

Cash Flows (Annual)

Figures in USD.

Metric Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Operating Cash Flow 161.40M225.40M347.78M190.00M1.06B1.12B673.00M804.00M-314.00M434.00M1.90B2.12B773.00M1.66B644.00M-535.00M
Investing Cash Flow -288.82M-236.93M-93.58M-543.00M-536.00M-1.42B-206.00M-1.06B1.14B-293.00M-400.00M-1.65B-790.00M-744.00M-464.00M312.00M
Financing Cash Flow 113.81M49.47M47.74M493.00M79.00M1.08B19.00M636.00M-1.19B-559.00M217.00M-183.00M-441.00M-58.00M-347.00M-170.00M
Capital Expenditure -----115.00M-132.00M-176.00M-86.00M-30.00M-57.00M-74.00M-77.00M-91.00M-84.00M-100.00M-101.00M
Free Cash Flow ----945.00M993.00M497.00M718.00M-344.00M377.00M1.82B2.04B682.00M1.58B544.00M-636.00M
Share Buybacks 07.00M3.00M53.00M00-0047.00M606.00M128.00M400.00M01.00B1.00B

Ratios (Annual)

Figures in %.

Metric Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Gross Margin % ---12.8%10.3%10.8%9.7%9.1%13.3%13.7%12.8%-----
Operating Margin % 2.6%3.0%0.7%2.1%2.0%2.7%1.7%-2.8%6.0%6.2%5.6%3.7%3.7%4.6%4.2%1.7%
Net Margin % 1.3%0.5%0.2%0.8%0.6%1.0%0.3%-2.6%3.7%4.4%3.5%2.4%2.5%3.2%2.9%1.0%
ROE % 7.6%2.8%1.3%5.9%6.1%9.2%3.2%-38.3%42.9%37.6%32.1%25.1%26.7%25.9%26.2%11.6%
ROCE % -12.9%3.7%8.1%8.5%14.1%10.6%-19.0%38.9%29.7%23.6%19.8%21.5%23.4%22.1%9.5%

Shareholding Pattern

Insiders
1.42%
Institutions
117.07%
Public Float
118.76%

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for MOH

Google News Mon, 03 Aug 2026

‘Big Short’ Investor Michael Burry Sticks With MOH Bet At $154 — Plans To Add More Shares - Stocktwits

<a href="https://news.google.com/rss/articles/CBMitwFBVV95cUxOLWpwX3hFaE41cXFNZmYxc0NGRU1aaUhoWTViemRCZkpYVXdsdDMxQXU4YlFWd05ZanNFQlkwaU9OV2pmSk9BclZ0OHlCbDJSWjJqbmR3bkZWV0NYMXNwZDBMTzhVclliZllxV09ROEM0dDc4T2tWZ3JSdTYtdnY0MmRuU3VHblRLVF9pUG…

Google News Mon, 15 Jun 2026

Is Molina Healthcare (MOH) a Great Value Stock Right Now? - Yahoo Finance

<a href="https://news.google.com/rss/articles/CBMinwFBVV95cUxNTVVVMmRJNTE3dzVDUVN2ZTFUdVMzQm9md09uV21NM3BzYzByYl83MUs4WW1kdjdzdktNMjNoRzdmRmp4RHhwQkhjMUgzbF9mQmNYWnBaM0czdzRsamYtNVpaVTJfQjNybkRXZE9FLS1hZGlpUUZzQW1XV3ZfaUJnTEdmQ3hsZFB6TWVKbj…

Google News ue, 04 Aug 2026

MOH|Molina Healthcare Inc|Price:194.740|Chg%:-0.880 - TradingKey

<a href="https://news.google.com/rss/articles/CBMiWEFVX3lxTFBFaVA0OHZZZGdNMDBvYmZQRzVEN1dJclpfLXp2ZlBSREo0NnBVaTRhQ0s3LTFaWktZTWNjaGNDci1zc3AtZG41b0dReXd1SkNZekNUekM1ZVY?oc=5" target="_blank">MOH|Molina Healthcare Inc|Price:194.740|Chg%:-0.…

Google News Fri, 31 Jul 2026

Molina Healthcare (MOH) Short Interest & Short Float | Updated Aug 2026 - MarketBeat

<a href="https://news.google.com/rss/articles/CBMiakFVX3lxTE5CVk5NVjdzYkFfcDAxbmgyRzNFYkVvc2xVVjFvcmlhYkVhR09GRU5CV2k2MHFYY2NfRGM3d1RRVnQ3ZVc4WmJLU1Fyc0gtX0FlamtBcHF1eHg4dlZOTzdUY3RLV2pac2NjQlE?oc=5" target="_blank">Molina Healthcare (MOH) …

Google News Wed, 22 Jul 2026

MOLINA HEALTHCARE ($MOH) Releases Q2 2026 Earnings | MOH Stock News - Quiver Quantitative

<a href="https://news.google.com/rss/articles/CBMikwFBVV95cUxOSm9ZOVktbzVheHRxMGVmUEpOY0FFdzhPcEZVaExzdUZnUDdpVXhMblYxRkU0b3NaV2F4dXhhVzlvYXAtNWN5NG5uRThDQmo2ekJCdUJ4dXNKVFpQNkdtQnV4ak5DYU96R213TVViY0ZHT2c2cUt1aWRfZ3ZLUG56bXE2V05VWVZ0TExKUC…

Google News Fri, 24 Jul 2026

Molina Healthcare (MOH) Stock Confronts Volatile Margins After Q2 Profit And Trailing Loss - simplywall.st

<a href="https://news.google.com/rss/articles/CBMi0AFBVV95cUxQV1cyd0pSb1RrMnI3U1dQWjJvVGlrSGhBcDF3cHVFMmcxbkpXalcyWDlFdVd5R0pIV3F1S0k3MTZSUzF6cGhJUGFrNi1HVGl4cjRqMnNVSEVVdzg2aEh2SHhSS0txZk5HY3JlTTBBa2ZsSXFSMFVZU2FzM18wR1hPa1ByQ04yNFZLVXZxMW…

MOH — Frequently Asked Questions

What is the current share price of MOH?

As of 2026-08-05 17:25 PDT, MOH trades at $195.14 on NASDAQ/NYSE. Its 52-week range is $122.65 to $242.88.

What is the P/E ratio of MOH?

MOH trades at a trailing price-to-earnings (P/E) ratio of 21.88.

What is the return on equity (ROE) of MOH?

MOH has a return on equity (ROE) of 11.60%. Its return on capital employed (ROCE) is 9.53%.

Is MOH a good stock to buy?

This page provides a data-driven analysis of MOH, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.

Explore More

🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All USA Stocks
⚙Ad space